MHRA Table of Approved Reclassifications Updated MHRA has updated the table of approved reclassifications 1991 to 2024, which contains the information on UK medicines reclassified from Prescription Only medicine (POM) to Pharmacy (P) medicine, and P medicine to General Sales List (GSL) medicine. The table now contains information up to 30 September 2024. MHRA Table of Approved Reclassifications Updated
MHRA Control Testing Guidance Updates Published MHRA has published updates to the following control testing guidance to reflect the requirements of the Windsor Framework. MHRA Control Testing Guidance Updates Published
CMDh Report from September 2024 Meeting The Co-ordination group for Mutual recognition and Decentralised procedures – human (CMDh) has published the report from the CMDh meeting held on 17-18 September 2024. CMDh Report from September 2024 Meeting
MHRA Launches Data Strategy MHRA has launched its first data strategy, setting out plans to improve ways the agency uses data to make decisions. MHRA Launches Data Strategy
Extended Producer Responsibility (EPR) Regulations for Packaging Update Defra has provided an update on the legislation for the introduction of Extended Producer Responsibility (EPR) reforms for packaging. Extended Producer Responsibility (EPR) Regulations for Packaging Update
Article on Basic Requirements and Framework Conditions of Real-World Data (RWD) on Herbal Medicinal Products A manuscript on “Basic Requirements and Framework Conditions of Real-World Data (RWD) on Herbal Medicinal Products” has been published in the Journal Planta Medica. Article on Basic Requirements and Framework Conditions of Real-World Data (RWD) on Herbal Medicinal Products
MHRA Marketing Authorisations Granted 1 to 14 September MHRA granted 2 OTC licenses during 1-14 September 2024. MHRA Marketing Authorisations Granted 1 to 14 September
PAGB Food Supplements Regulatory Workshop The upcoming PAGB Food Supplements Regulatory Workshop will take place in person on Thursday, 10 October, at PAGB's office from 10:00 AM to 4:00 PM. PAGB Food Supplements Regulatory Workshop
Application Route for Performance Studies Under the In Vitro Diagnostics Regulations in Northern Ireland The MHRA has announced the approval of the first application for In Vitro diagnostic devices under the EU IVDR in Northern Ireland due to recent implementation of a submission route for manufacturers for performance studies. Application Route for Performance Studies Under the In Vitro Diagnostics Regulations in Northern Ireland
MHRA Strategy for Improving Safety Communications 2024 – 2027 MHRA has published their 3-year strategy for improving safety communications for 2024 to 2027. The strategy sets out MHRA’s ambition to transform the way they communicate about the risks and safety of medicines, medical devices and healthcare products in the UK to support effective implementation of new safety measures. MHRA Strategy for Improving Safety Communications 2024 – 2027
MHRA Data Strategy 2024 – 2027 Published MHRA has published its its data strategy 2024-2027. MHRA Data Strategy 2024 – 2027 Published
MHRA Webinar “Medicines Pipelines – MHRA’s new forecasting process” MHRA Webinar on medicines pipelines and MHRA’s new forecasting process MHRA Webinar “Medicines Pipelines – MHRA’s new forecasting process”
